| Breakdown | TTM | Nov 2025 | Nov 2024 | Nov 2023 | Nov 2022 | Nov 2021 |
|---|---|---|---|---|---|---|
Income Statement | ||||||
| Total Revenue | 181.64B | 182.82B | 170.91B | 158.33B | 147.42B | 110.88B |
| Gross Profit | 11.49B | 12.29B | 10.07B | 7.91B | 7.46B | 6.64B |
| EBITDA | 6.03B | 6.45B | 4.88B | 3.55B | 3.30B | 3.08B |
| Net Income | 4.29B | 4.32B | 3.15B | 2.05B | 2.29B | 1.96B |
Balance Sheet | ||||||
| Total Assets | 92.90B | 90.21B | 81.44B | 72.04B | 73.46B | 52.90B |
| Cash, Cash Equivalents and Short-Term Investments | 10.36B | 10.16B | 9.08B | 7.78B | 6.38B | 5.51B |
| Total Debt | 43.20B | 37.15B | 33.43B | 31.52B | 31.26B | 19.53B |
| Total Liabilities | 63.47B | 57.76B | 53.85B | 47.31B | 50.98B | 33.32B |
| Stockholders Equity | 29.43B | 32.45B | 27.58B | 24.72B | 22.48B | 19.58B |
Cash Flow | ||||||
| Free Cash Flow | 0.00 | -1.34B | 79.00M | 2.11B | -10.56B | -4.20B |
| Operating Cash Flow | 0.00 | -268.00M | 636.00M | 3.22B | -10.41B | -4.04B |
| Investing Cash Flow | 0.00 | -1.51B | -596.00M | -1.36B | -287.22M | -291.56M |
| Financing Cash Flow | 0.00 | 2.43B | 1.10B | -772.20M | 11.08B | 4.66B |
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
|---|---|---|---|---|---|---|---|
82 Outperform | ¥62.76B | 8.46 | ― | 3.63% | -0.05% | 15.54% | |
68 Neutral | ¥194.60B | 4.56 | ― | 2.47% | -0.47% | 22.89% | |
62 Neutral | $20.33B | 14.63 | -3.31% | 3.23% | 1.93% | -12.26% | |
62 Neutral | ¥1.03T | 13.62 | 5.97% | 2.96% | 1.21% | -5.73% | |
59 Neutral | ¥33.24B | 12.38 | ― | 3.84% | 4.65% | 10.02% | |
59 Neutral | ¥410.05B | 10.37 | ― | 2.42% | 2.48% | -0.58% | |
56 Neutral | ¥46.29B | 18.12 | 1.97% | 2.92% | -1.45% | 96.52% |